The recently launched TREAT-MS study is a pragmatic trial to evaluate the intermediate-term effects of early, aggressive versus escalation therapy in people with multiple sclerosis.

In a study using longitudinal in vivo two-photon imaging of oligodendrocytes and their progenitors in the mouse cerebral cortex, we show that myelination is an inefficient and extended process, with half of the final complement of oligodendrocytes generated after 4 months of age.

Learn more about how the NMO Lab is developing tests for these rare diseases and see how you can support these efforts.

Johns Hopkins researchers are learning more about the anti-inflammatory effects of dimethyl fumarate, its effects on cellular energy metabolism, and what this could mean for future directions in MS therapies.

A designer introduces friendly icons to spread awareness and spark conversation about the invisible symptoms of MS.

The Neurosciences Consultation and Infusion Center at Green Spring Station offers a comfortable environment for infusion therapy in a convenient location.

Melinda Smith, who is living with MS, shares her journey and talks about how and why she gives back to support MS research.

The Project RESTORE Athletic Team (PRAT) is tying on its running shoes once again to raise funds at the Baltimore Triathlon Sprint Relay on Sunday, September 30th.